Maria Fuensanta
Hellin Gil
Hospital Universitario de la Princesa
Madrid, EspañaPublikationen in Zusammenarbeit mit Forschern von Hospital Universitario de la Princesa (1)
2023
-
Cost-Analysis of Subcutaneous vs Intravenous Administration of Natalizumab Based on Patient Care Pathway in Multiple Sclerosis in Spain
PharmacoEconomics - Open, Vol. 7, Núm. 3, pp. 431-441